Cynthia Chmielewski | CureTalks
Cynthia attended Rutgers University graduating with degrees in Psychology and Education. Upon graduation she secured her first teaching position and immediately fell in love with her chosen profession. Cynthia continued teaching for 28 years. Now retired, Cynthia, a myeloma survivor, is using her passion for education to teach a new group of "students" - myeloma patients and their caregivers. She is on the advisory boards of the Patient Empowerment Network, the Myeloma Crowd and the Philadelphia Multiple Myeloma Networking Group. Using social media to educate is her passion. Cynthia educates and advocates by tweeting at @MyelomaTeacher and sharing myeloma resources, educational opportunities and clinical trial information on her MyelomaTeacher Facebook page. Ms. Chmielewski is the co-founder of the #MMSM TweetChat and is also a regular panelist on CureTalks Podcast. Cynthia was an invited panelist and presented posters on using social media in hematology at the annual meetings of the American Society of Hematology (ASH), the American Association for Cancer Research (AACR) and the European Bone Marrow Transplant (EBMT). More recently Cynthia joined the Patient Engagement team at Patient Power. Additionally, she consults on educational projects sponsored by the Myeloma Crowd. She enjoys serving as a voting member on the IRB at the University of Pennsylvania, a peer reviewer for the NCI’s DEA grants program and a patient advocate on the Myeloma Steering Committee of the National Cancer Institute (NCI) and ACCRU. Cynthia has also participated in the Department of Defense’s CMCRP grant reviews.
Related Talks
Myeloma 2015. Year in Review with the MMRF
2015 saw a lot of action in the Myeloma world. Four new drugs were approved by the FDA increasing treatment options and allowing…
A Novel, More Precise, and Effective T-Cell Immunotherapy Approach for Myeloma
A lot of research is being done in immunotherapy for myeloma that is leading to new treatment options for patients. Dr. Ivan Borrello of…
Understanding Multiple Myeloma: Types of Diagnostic Tests and Frequency
Myeloma presents itself differently in each patient. In order to understand your Myeloma and monitor it, you need to know which are the…
MSKCC Expert Dr. Ola Landgren on Can High Risk Disease Progress Cure Myeloma ?
Is high risk disease progress, the key to a cure for all myeloma patients? And what can researchers do to get new therapies…
CAR Therapy for Myeloma Treatment with Dr. Craig Hofmeister
CS1-CAR is a new and radically different approach in cancer treatment that harnesses the power of the patients immune system to rid itself…